CD19 CAR-T in the Treatment of Relapsed/Refractory Autoimmune Diseases
Clinical trial NCT06680388 · RECRUITING
Trial details
- NCT number
- NCT06680388
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-15
- Primary completion
- 2027-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.